Hi Grade: In Year's Biggest Deal, Medtronic Inks $17B Bond Offering Backing Covidien Buy |
December 02, 2014 | December 2014 Bond Updates |
Medical device manufacturer Medtronic today placed a $17 billion offering across seven tranches of 144A/Reg S senior notes as much as 25 bps through early whispers, as it locks in funds to back the $16 billion cash consideration of its blockbuster $43 billion acquisition of Dublin-based peer Covidien. The deal was weighted to longer-dated issues, including the largest single tranches ($4 billion each of 10- and 30-year issues) inked since last September. |
View more at: http://www.forbes.com/sites/spleverage/2014/12/01/hi-grade-in-years-biggest-deal-medtronic-inks-17b-bond-offering-backing-covidien-buy/ |
Related News |
|